Synthroid Cost in New York 2026: Prices, Insurance, Medicaid, and Compounded Options

What Does Synthroid Actually Cost in New York in 2026?

Branded Synthroid (levothyroxine sodium, AbbVie) carries a manufacturer list price of roughly $50 per month in New York. Generic levothyroxine tablets from manufacturers such as Mylan, Lannett, and Amneal average $15 per month at retail pharmacies across the state, though prices vary by dose strength and pharmacy chain. Patients who use discount cards or GoodRx-style platforms can often bring that figure down to $4 to $10 per 30-day supply at high-volume New York pharmacies.

The price gap between brand and generic matters because the FDA has designated multiple generic levothyroxine formulations as therapeutically equivalent to Synthroid under the "AB" rating system, meaning automatic substitution is legally permitted in New York unless a prescriber writes "dispense as written." The FDA's Orange Book entry for levothyroxine sodium tablets confirms this therapeutic equivalence rating. For most stable hypothyroid patients, switching from branded Synthroid to a consistently supplied generic from a single manufacturer carries no meaningful clinical risk, provided the manufacturer is not changed mid-therapy without a TSH recheck in 6 to 8 weeks.

The American Thyroid Association (ATA) and the American Association of Clinical Endocrinology note in their joint 2014 guidelines that levothyroxine remains the standard of care for hypothyroidism, with lifelong daily dosing typically required. The 2014 ATA/AACE hypothyroidism guidelines (Jonklaas et al., Thyroid 2014) are indexed at PubMed PMID 25266247. Dose adjustments are guided by serum TSH measured 6 to 8 weeks after any change, with a target TSH of 0.5 to 2.5 mIU/L for most adults. FDA-approved Synthroid prescribing information is maintained at AccessData.FDA.gov.

Price varies meaningfully by dose. A 25 mcg tablet costs less per unit than a 125 mcg tablet. Patients on higher doses may pay proportionally more per month, so confirming the correct strength with your pharmacist before assuming a generic price applies to your specific dose is worth the 90-second conversation.

How New York Medicaid Covers Levothyroxine

New York Medicaid covers levothyroxine for hypothyroidism, but requires prior authorization (PA) for branded Synthroid. Generic levothyroxine is on the preferred drug list in most New York Medicaid managed care plans without PA, making the path to zero copay straightforward for most enrolled patients.

New York State Medicaid covers approximately 8.1 million enrollees as of 2024, according to CMS data. For the majority of those patients diagnosed with primary hypothyroidism (ICD-10 E03.9) or Hashimoto thyroiditis (ICD-10 E06.3), generic levothyroxine is covered at no cost to the patient under Medicaid managed care. CMS guidance on Medicaid preferred drug list structures is available at Medicaid.gov.

When a prescriber determines that a patient requires branded Synthroid rather than a generic, a PA request must document medical necessity. Acceptable documentation typically includes a history of bioequivalence issues on generic, a narrow therapeutic index concern, or documented TSH instability that correlated with a manufacturer change. The PA approval process in New York Medicaid managed care plans averages 3 to 5 business days for standard reviews and 24 to 72 hours for urgent requests under New York State Insurance Law.

Dual-eligible patients (Medicare plus Medicaid) access levothyroxine through their Medicare Part D plan. Generic levothyroxine appears on Tier 1 of most Part D formularies, meaning a copay of $0 to $5 per month for most low-income subsidy (LIS) beneficiaries. Medicare Part D formulary tier structures are described by CMS at cms.gov.

New York also operates the Essential Plan, a low-cost coverage option for adults earning 138 to 200 percent of the federal poverty level who are not Medicaid-eligible. Generic levothyroxine is covered under the Essential Plan drug benefit at a $0 to $3 copay tier at most participating pharmacies. Essential Plan benefits are outlined by the NY State of Health marketplace at nystateofhealth.ny.gov.

Does Commercial Insurance Cover Synthroid in New York?

Most commercial plans sold in New York cover generic levothyroxine on Tier 1 with a $0 to $15 copay per 30-day supply. Branded Synthroid typically lands on Tier 2 or Tier 3, where copays range from $25 to $75 per month depending on the plan's benefit design.

The Affordable Care Act requires most non-grandfathered commercial plans to cover preventive services without cost sharing, but hypothyroidism treatment is not classified as preventive under USPSTF Grade A/B recommendations for general screening; therefore standard drug benefit cost-sharing applies. USPSTF concluded in its 2015 review that evidence is insufficient to recommend routine thyroid screening in asymptomatic non-pregnant adults (Grade I).

New York's community rating laws and the state's Essential Health Benefits benchmark mean all qualified health plans sold on or off the NY State of Health marketplace must include a comprehensive prescription drug benefit. That benefit must cover at least one drug in every therapeutic class, which in practice means at least one levothyroxine formulation is covered on every compliant plan.

Patients on Tier 3 or Tier 4 branded Synthroid can use AbbVie's myAbbVie Assist program. Commercially insured patients may qualify for a savings card that reduces their branded Synthroid copay to $0 per month. AbbVie's patient assistance information is listed at AbbVie.com and referenced through the NeedyMeds database at needymeds.org. Uninsured or underinsured patients who meet income thresholds may qualify for Synthroid at no cost through the AbbVie Patient Assistance Foundation. Applications require proof of income and a valid New York prescription.

Important: AbbVie savings cards cannot be used by patients with Medicaid, Medicare, or other federal health programs. That restriction is standard across branded drug copay cards and is not specific to Synthroid.

Is Compounded Levothyroxine Legal in New York?

Compounded levothyroxine is legal in New York when prepared by a licensed 503A compounding pharmacy operating under New York State Board of Pharmacy oversight. It is not interchangeable with FDA-approved levothyroxine tablets and carries a different regulatory profile.

Section 503A of the federal Food, Drug, and Cosmetic Act permits patient-specific compounding by licensed pharmacies when a valid prescription from a licensed prescriber exists, the compound is not essentially a copy of a commercially available drug, and the pharmacy complies with USP standards. FDA's guidance on 503A compounding is published at FDA.gov. In New York, the Board of Pharmacy enforces additional state-level standards through Title 8 NYCRR Part 29 and Part 63, including sterility testing requirements, beyond-use dating, and labeling rules.

Compounded levothyroxine is most commonly prescribed in New York in the following clinical situations: a patient requires a non-commercially available dose strength (for example, 13 mcg for fine titration in elderly patients or pediatric cases), a patient has a documented allergy to an inactive ingredient in all commercial formulations (such as acacia or dye), or a prescriber prefers a liquid suspension for a patient who cannot swallow tablets.

The "not essentially a copy" rule creates a significant legal constraint. A compounding pharmacy cannot legally prepare plain 50 mcg, 75 mcg, or 100 mcg levothyroxine tablets for a patient if that strength is commercially available, unless a documented clinical reason for compounding exists. FDA's draft guidance on "essentially a copy" determinations is available at FDA.gov.

Cost of compounded levothyroxine in New York varies widely. Some 503A pharmacies offer it at near $0 out of pocket when a health share plan or self-pay arrangement is in place, but most commercial insurers do not cover 503A-compounded medications unless a medical necessity exception is approved. Patients considering compounded levothyroxine should confirm their pharmacy's state licensure status through the New York State Office of the Professions license lookup before filling a prescription.

Telehealth Prescribing of Synthroid and Levothyroxine in New York

New York permits telehealth prescribing of levothyroxine by licensed physicians, nurse practitioners, and physician assistants who hold a New York State license and have established a valid prescriber-patient relationship. A controlled substance DEA registration is not required for levothyroxine because it is not a scheduled drug.

New York Public Health Law Section 2999-cc governs telehealth services and requires that the prescriber use an appropriate technology platform, that the standard of care is met, and that the patient receives adequate follow-up. Telehealth visits for hypothyroidism management are covered by most commercial plans in New York under the state's telehealth parity law, which requires commercial insurers to reimburse telehealth visits at the same rate as in-person visits for equivalent services.

A telehealth provider diagnosing hypothyroidism de novo will typically require laboratory confirmation (TSH <0.5 or >4.5 mIU/L, free T4 below reference range) before initiating levothyroxine. Starting dose for adults without cardiac disease is commonly 1.6 mcg/kg/day of lean body weight, with lower starting doses of 25 to 50 mcg/day in patients over 65 or with known or suspected coronary artery disease, per ATA 2014 recommendations. Jonklaas et al., ATA 2014 guidelines, PubMed PMID 25266247.

Telehealth visits in New York range from $0 with in-network commercial insurance to $49 to $149 per visit on direct-pay telehealth platforms. Prescription transmission to a New York pharmacy is handled electronically. Labs can be ordered to any CLIA-certified draw site in the state. FDA oversight of prescription drug dispensing via telehealth is described at FDA.gov.

The Cheapest Ways to Get Levothyroxine in New York Right Now

Several strategies consistently produce the lowest out-of-pocket costs for New Yorkers filling levothyroxine prescriptions.

GoodRx and discount platforms. GoodRx, RxSaver, and NeedyMeds offer free discount coupons that reduce generic levothyroxine to $4 to $10 per 30-day supply at major New York chains including CVS, Walgreens, Rite Aid, and Duane Reade. The coupon is used instead of insurance, not in addition to it. GoodRx pricing transparency is referenced in a JAMA Internal Medicine 2018 analysis of retail drug pricing variability.

Walmart $4 generic list. Walmart's $4/$10 generic program includes several strengths of generic levothyroxine. A 90-day supply can cost as little as $10 at Walmart pharmacy locations in New York, including stores in the Bronx, Brooklyn, Staten Island, and suburban areas.

90-day supply instead of 30-day. Filling a 90-day supply typically costs less per tablet than three separate 30-day fills. Most commercial plans and Medicaid managed care plans in New York allow 90-day fills for maintenance medications. Mail-order pharmacy through your insurer's pharmacy benefit manager (PBM) often reduces the per-tablet cost further.

Mark Cuban's Cost Plus Drugs. CostPlusDrugs.com sells generic levothyroxine at transparent cost-plus-15-percent pricing with a flat $5 dispensing fee, shipped to New York. As of mid-2025, levothyroxine 50 mcg (90 tablets) lists at approximately $5.10 on the platform, making it one of the lowest verified prices available without a coupon. Cost Plus Drugs pricing methodology is described at costplusdrugs.com and referenced in health economics literature indexed at PubMed.

New York State Pharmaceutical Assistance Program (EPIC). The Elderly Pharmaceutical Insurance Coverage (EPIC) program assists New Yorkers aged 65 and older who do not qualify for Medicaid but have limited income. Generic levothyroxine is covered under EPIC with nominal copays. EPIC program details are at health.ny.gov.

340B covered entity pharmacies. New Yorkers who receive care at Federally Qualified Health Centers (FQHCs), Ryan White HIV/AIDS program sites, or other 340B-covered entities may access levothyroxine at 340B pricing, which can be below $2 per month. HRSA's 340B program database is searchable at hrsa.gov.

Understanding Your Levothyroxine Prescription in New York

Levothyroxine is a narrow therapeutic index (NTI) drug, meaning small dose changes produce clinically meaningful shifts in thyroid hormone levels. The FDA classifies levothyroxine as an NTI drug for the purpose of bioequivalence standards, requiring that generic formulations meet tighter bioequivalence windows (90 to 111.11 percent) than non-NTI drugs. FDA's bioequivalence guidance for NTI drugs is at FDA.gov.

This classification has two practical implications for New York patients. First, if a pharmacy switches you from one generic manufacturer to another, your TSH should be rechecked 6 to 8 weeks later. Second, branded Synthroid's consistent formulation is sometimes preferred by endocrinologists managing patients whose TSH has been difficult to stabilize on generics, which is the clinical basis for a PA request under New York Medicaid.

Levothyroxine is taken once daily on an empty stomach, 30 to 60 minutes before the first meal, coffee, or any other medication. Calcium carbonate, iron supplements, cholestyramine, and proton pump inhibitors all reduce levothyroxine absorption and should be spaced at least 4 hours apart. Drug interaction data for levothyroxine is detailed in the FDA prescribing label at AccessData.FDA.gov.

A 2014 meta-analysis by Liwanpo and Hershman (published in the American Journal of Medicine, indexed at PubMed) documented that concurrent calcium administration reduced levothyroxine absorption by 20 to 40 percent in controlled studies, a finding directly relevant to patients who take both supplements and thyroid medication in the morning.

Pregnancy changes levothyroxine requirements substantially. Most women with pre-existing hypothyroidism need a 25 to 30 percent dose increase immediately upon confirmed pregnancy. The Endocrine Society's 2012 clinical practice guideline on thyroid disease in pregnancy (indexed at PubMed PMID 22869843) recommends TSH monitoring every 4 weeks through mid-gestation.

How Levothyroxine Dosing Affects Your Monthly Cost in New York

Dose strength and tablet count directly determine what you pay at the pharmacy counter. Most adult hypothyroid patients require 50 to 200 mcg per day, with 75 mcg, 100 mcg, and 125 mcg being the three most frequently prescribed strengths in the United States. Prescribing frequency data for levothyroxine are reported in FDA's annual Drug Safety Communication database at FDA.gov.

Generic prices at New York retail pharmacies in 2026 by dose strength (approximate, cash-pay with discount card):

50 mcg (30 tablets): $4 to $8. 100 mcg (30 tablets): $6 to $10. 125 mcg (30 tablets): $8 to $15. 150 mcg (30 tablets): $9 to $16. 200 mcg (30 tablets): $10 to $18.

Patients splitting higher-dose tablets to achieve a lower dose should know that levothyroxine tablets are scored in some strengths but the practice affects dose accuracy and is generally not recommended for NTI drugs without explicit prescriber instruction. FDA guidance on tablet splitting for NTI drugs is discussed at FDA.gov.

When Branded Synthroid May Be Worth the Higher Cost in New York

Generic levothyroxine is appropriate for the majority of New York patients with straightforward primary hypothyroidism. Branded Synthroid may be worth the higher cost, or medically necessary, in a narrow set of situations.

A 2017 study by Jansen et al. in the Journal of Clinical Endocrinology and Metabolism (PubMed PMID 28323989) found no clinically meaningful difference in TSH control between branded and generic levothyroxine when the same generic manufacturer was used consistently. The problem arises when the dispensed manufacturer changes between refills, which happens more often in high-volume retail settings.

Patients with thyroid cancer on intentional TSH suppression (target TSH <0.1 mIU/L) may benefit from the dose-to-dose consistency of branded Synthroid, as small variations in absorption could affect suppression targets. Pediatric patients, pregnant patients in the first trimester, and patients with complex absorption disorders (celiac disease, short bowel syndrome) are additional populations where branded formulations may be preferred.

If your New York insurer or Medicaid plan will not cover branded Synthroid without a PA, ask your endocrinologist to document one of the above rationales in the PA request. Approval rates improve with specific clinical documentation rather than a generic "patient prefers brand" notation.

New York Pharmacy Options for Levothyroxine

New York offers an extensive pharmacy network. Major retail chains (CVS, Walgreens, Rite Aid, Duane Reade, Costco, Walmart), independent pharmacies, mail-order PBM pharmacies (Express Scripts, OptumRx, CVS Caremark), and specialty compounding pharmacies all dispense levothyroxine in New York.

The National Community Pharmacists Association reports that independent pharmacies fill approximately 35 percent of all retail prescriptions nationally, and in New York City particularly, independent neighborhood pharmacies often match or beat chain pricing for generics when a GoodRx coupon is applied.

Costco Pharmacy in New York locations offers generic levothyroxine at member pricing that often competes with GoodRx rates without requiring a coupon. Membership is required for pharmacy services at most Costco locations, though federal law (in certain states) allows non-members to use warehouse club pharmacies. New York does not have a specific statute requiring Costco to serve non-members, so membership is effectively required at New York Costco pharmacies.

For patients without easy physical access to a pharmacy, mail-order through your insurance plan's PBM is available. A 90-day supply by mail typically costs $0 to $15 with commercial insurance and is a reliable option for stable patients whose dose has not changed in more than 6 months. CMS data on Medicare mail-order pharmacy utilization is at cms.gov.